Tonix Meds Drug Patent Portfolio

Tonix Meds owns 2 orange book drugs protected by 10 US patents Given below is the list of Tonix Meds's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10537554 Pharmaceutical composition for treating migraine 29 Jan, 2036
Active
US11364224 Pharmaceutical composition for treating migraine 29 Jan, 2036
Active
US9211282 Formulations comprising triptan compounds 19 Jul, 2031
Active
US10603305 Formulations comprising triptan compounds 16 Jun, 2030
Active
US11337962 Formulations comprising triptan compounds 16 Jun, 2030
Active
US9610280 Formulations comprising triptan compounds 16 Jun, 2030
Active
US9974770 Formulations comprising triptan compounds 16 Jun, 2030
Active
US8268791 Alkylglycoside compositions for drug administration 09 May, 2026
Active
US8440631 Compositions for drug administration 09 May, 2026
Active
US9283280 Compositions for drug administration 09 May, 2026
Active


Given below is the list of recent legal activities going on the following drug patents of Tonix Meds.

Activity Date Patent Number
Patent litigations
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 14 May, 2024 US10603305
Email Notification 07 May, 2024 US9974770
Change in Power of Attorney (May Include Associate POA) 07 May, 2024 US9974770
Change in Power of Attorney (May Include Associate POA) 25 Apr, 2024 US11337962
Email Notification 25 Apr, 2024 US11337962
Email Notification 24 Apr, 2024 US10537554
Email Notification 24 Apr, 2024 US9211282
Change in Power of Attorney (May Include Associate POA) 24 Apr, 2024 US11364224
Change in Power of Attorney (May Include Associate POA) 24 Apr, 2024 US9211282
Change in Power of Attorney (May Include Associate POA) 24 Apr, 2024 US10603305
Email Notification 24 Apr, 2024 US10603305
Email Notification 24 Apr, 2024 US9610280
Change in Power of Attorney (May Include Associate POA) 24 Apr, 2024 US9610280
Change in Power of Attorney (May Include Associate POA) 24 Apr, 2024 US10537554
Email Notification 24 Apr, 2024 US11364224


Tonix Meds's Family Patents

Tonix Meds drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 45.3% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Tonix Meds Drug List

Given below is the complete list of Tonix Meds's drugs and the patents protecting them.


1. Tosymra

Tosymra is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9211282 Formulations comprising triptan compounds 19 Jul, 2031
(6 years from now)
Active
US10603305 Formulations comprising triptan compounds 16 Jun, 2030
(5 years from now)
Active
US11337962 Formulations comprising triptan compounds 16 Jun, 2030
(5 years from now)
Active
US9610280 Formulations comprising triptan compounds 16 Jun, 2030
(5 years from now)
Active
US9974770 Formulations comprising triptan compounds 16 Jun, 2030
(5 years from now)
Active
US8268791 Alkylglycoside compositions for drug administration 09 May, 2026
(1 year, 6 months from now)
Active
US8440631 Compositions for drug administration 09 May, 2026
(1 year, 6 months from now)
Active
US9283280 Compositions for drug administration 09 May, 2026
(1 year, 6 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tosymra's drug page


2. Zembrace Symtouch

Zembrace Symtouch is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10537554 Pharmaceutical composition for treating migraine 29 Jan, 2036
(11 years from now)
Active
US11364224 Pharmaceutical composition for treating migraine 29 Jan, 2036
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zembrace Symtouch's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List